Roche Avastin Injections Linked to Blindness - Aug. 31, 2011

Having trouble viewing this email? View in Browser.

Wednesday, August 31, 2011  |   |   |   |  At Aptuit's MHRA certified and FDA inspected multi-purpose manufacturing site in Oxford, England, we can produce highly potent compounds at commercial scale in accordance with the highest safety and quality standards. Please click here for more information.   •  Roche (RHHBY) Avastin Injections Linked to Blindness More... •  Bristol-Myers Squibb Company (BMY)'s Sprycel Linked to Potentially Fatal Side-Effect: Health Canada Reports More... •  OrbiMed Launches $600 Million Fund to to Lure Life Science Companies Looking for Quick Cash More... •  Ardelyx Inc. Closes $30 Million Series B Financing More... •  FDA Chemist's Insider Trading Case Nears Plea Bargain More... •  Argonne National Laboratory Begins $34.5 Million Facility, Expected to Create 550 Jobs More... •  Positive Results for Phase III Pediatric Trial with Eisai Inc. (ESALF.PK)'s Zonegran Epilepsy Drug More... •  Head-to-Head Data on AstraZeneca PLC (AZN)'s Crestor Vs. Pfizer Inc. (PFE)'s Lipitor Results Due Soon More... More Top News 2011 Bioscience Vision Summit Thursday, September 8, 2011 Madison Marriott West, Middleton WI Join the nearly 400 people who have already registered, for provocative and informed discussions on advancing the industry. From drug development and medical devices, to creating the bioenergy supply chain , to bridging the divide between organic farming and genetic engineering, this year's event promises to bring together leaders who are creating the products and jobs of the future. Hear from Ernst & Young the results of their 2011 Global Biotechnology Report, participate in sessions on bridge financing, corporate governance and incorporating lean principles into your own business, and discuss challenges and solutions unique to the industry. New this year - 16 career sessions, and 5 lab application seminars for scientists and students interested in advancing their careers. Please click here for more information. Life Science Map Spotlights Northern California Companies BioSpace.com launched the 16th edition of the Biotech Bay® Hotbed Campaign this morning, highlighting companies across the United States. Click here to find the Biotech Bay Hotbed homepage. Click here to find the 2011-2012 Biotech Bay campaign map. •  Why Docs Are Skittish About Prescribing Dendreon Corporation (DNDN)'s Provenge More... •  Flame Retardants Tied to Lower Birth Weights, University of California, Berkeley (CAL) Study More... •  Black Death Bacteria Strain Probably Extinct, McMaster University Reveals More... •  What You Eat Affects Viruses Living in the Gut, University of Pennsylvania School of Medicine Study More... •  Blood Protein Might Signal Death Risk in Elderly, Uppsala Universitet Study More... •  More Evidence Links Genes to Parkinson's, Feinstein Institute Study More... •  Family Heart Disease Risk Linked to Genes, Not Lifestyle, Center for Primary Health Care Research Study More... •  Bacteria Turn Newspapers Into Biofuel, Tulane University Study More...   More Featured News Sep 15, 2011 - BayBio Life Science Series Venture Spotlight | Planning for Exit A panel of seasoned VC investors and life science executives who have recently navigated a successful exit will discuss the current state of the life science M&A and IPO markets and the tradeoffs between the two, when and how companies and investors should evaluate exit opportunities, key deal terms that are heavily negotiated in exit transactions and the venture capitalists' role in the exit process. Please click here for more information. Advancing Molecular Diagnostics to Personalize Cancer Therapy • Identify key innovations in molecular diagnostics for oncology that may compete with those in development at your company. • Understand the regulatory challenges facing the developers of molecular diagnostics for cancer. • Understand the challenges that surround successfully commercializing a combined drug-diagnostic product and learn how to overcome them. • Discover and analyze the key technology platforms being used in the development of novel molecular diagnostics. Click Here for More Information Nature Methods Nature Methods provides techniques for life scientists and chemists. It is a print and online publication dedicated to publishing novel methods together with significant advances to tried and tested techniques allowing researchers to perform faster, better and more efficient experimental research. Request Now! • Pharm Country (Rochester, New York) Vaccinex, Inc. Director, Clinical Development Responsible for providing clinical direction, clinical operations management, and clinical safety review for the companys ongoing clinical trials in oncology and multiple sclerosis, as well as providing advanced leadership in the clinical aspects of drug development and protocol design for these indications. • Bio NC (Research Triangle Park, North Carolina) Advanced Liquid Logic Scientist/Enzymologist Responsible for planning, designing and running experiments for the purpose of assay development and translation for the purpose sample preparation development and translation. The primary focus is to assist with the transition of research results to useful and manufacturable products, developing core Biochemistry competencies and translating to the digital microfluidic platform. • Genetown (Cambridge, Massachusetts) Acceleron Pharma Associate Director/Director Quality Assurance Manage the systems and procedures that ensure compliance with ICH guidelines and FDA/EMEA applicable regulations (cGLP, cGMP, cGCP). Ensure that company procedures are consistent with clinical and development activities. • BioCapital (Frederick, Maryland) SAIC-Frederick, Inc. Research Associate III Responsible for contacting and interacting with equipment representatives; negotiating costs for equipment and determining the best options for purchases; establishing space for microscopy set-up; initializing stock; arranging laboratory space; training new post-docs in cell biology and microscopy techniques; maintaining tissue culture cell lines; participating in biochemical/mass spec studies aimed at characterizing centrosome components; preparing manuscripts and presenting results at meetings. • BioForest (Eugene, Oregon) Life Technologies Scientist III, Production Responsible for technical troubleshooting of products and manufacturing processes, for the development and transfer of new products, and for initiating process improvements in organic chemistry production at the Eugene site. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Biotech Beach Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Beach Career Fair, San Diego, CA September 22, 2011 • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services The Biotechnology Initiative 1185 Eglinton Avenue East, Suite 104 Toronto, Ontario M3C 3C6 Canada Phone: 416-426-7293 Fax: 416-426-7280 The Biotechnology Initiative is a non-profit organization committed to promoting the growth of biotechnology in Ontario. While biopharmaceuticals and diagnostics are core strengths of this community, it also has broad research capability and growing commercial activity in agri-food biotechnology as well as the emerging resource and environmental biotech industries. More Company Profiles FREE Subscription to Pharmaceutical Executive Pharmaceutical Executive is a publication designed to meet the diverse management and marketing needs of professionals in the pharmaceutical industry worldwide. Editorial provides useful information on marketing, sales and promotion, as well as legal and regulatory issues. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.